'No hourly billing, no shadow invoices, no nothing' - how GSK got tough on fixed fees

The pharma giant has taken an increasingly hard line with external advisers in a move to ditch the billable hour entirely

I’ve been having a lot of conversations lately about alternative fee arrangements (AFAs).

In an earlier column, I wrote that the death of the billable hour has been one of the most consistently overhyped non-events in the history of Big Law. Indeed, despite the move to AFAs having been heralded for decades, the majority of high-value mandates are still handled on the clock.

This premium content is reserved for
Legal Week Subscribers.

Continue reading by getting
started with a subscription.

Subscribe Now For Unlimited Access

For enterprise-wide or corporate enquires, please contact David Sampson on corpsubslegalweek@alm.com